When an increasing trend of utilization of certain drugs is associated with a decreasing trend of reporting serious adverse events, this points to a good safety profile of such drugs and precludes the necessity for further observational pharmacovigilance studies, except for spontaneous reporting.
← all excerpts
Analysis of Reporting Trends of Serious Adverse Events Associated With Anti-Obesity Drugs.
1
—
—